SCB-719

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameSCB-719
Drug Alias NameSCB-719SCB-142
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionT-cell surface antigen CD4 modulators
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesClover Biopharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClover Biopharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A